Robust neutralizing antibodies to SARS-CoV-2 develop and persist in subjects with diabetes and COVID-19 pneumonia
Articolo
Data di Pubblicazione:
2021
Citazione:
Robust neutralizing antibodies to SARS-CoV-2 develop and persist in subjects with diabetes and COVID-19 pneumonia / Dispinseri, Stefania; Lampasona, Vito; Secchi, Massimiliano; Cara, Andrea; Bazzigaluppi, Elena; Negri, Donatella; Brigatti, Cristina; Pirillo, Maria Franca; Marzinotto, Ilaria; Borghi, Martina; Rovere-Querini, Patrizia; Tresoldi, Cristina; Ciceri, Fabio; Scavini, Marina; Scarlatti, Gabriella; Piemonti, Lorenzo. - In: THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM. - ISSN 0021-972X. - (2021). [Epub ahead of print] [10.1210/clinem/dgab055]
Abstract:
The aim of this study was to characterise the kinetics and durability of neutralizing antibody (Nab) response against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the presence of hyperglycemia.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
COVID-19; Neutralizing antibodies; SARS-CoV-2; diabetes; humoral response; survival rate
Elenco autori:
Dispinseri, Stefania; Lampasona, Vito; Secchi, Massimiliano; Cara, Andrea; Bazzigaluppi, Elena; Negri, Donatella; Brigatti, Cristina; Pirillo, Maria Franca; Marzinotto, Ilaria; Borghi, Martina; Rovere-Querini, Patrizia; Tresoldi, Cristina; Ciceri, Fabio; Scavini, Marina; Scarlatti, Gabriella; Piemonti, Lorenzo
Link alla scheda completa:
Pubblicato in: